ACQUISITION OF THE NON-PNUME PHARMACEUTICAL PRODUCT ATEZOLIZUMAB 60MG/ML INJECTABLE X 20 ML (1200 MG) INJECTABLE FOR A 12-MONTH SUPPLY

This tender concerns the direct procurement of the pharmaceutical product Atezolizumab, specifically in a 60mg/ml injectable formulation, presented in 20 ml vials (equivalent to 1200 mg). The acquisition is intended to ensure a supply of this critical medication for a period of 12 months. The contracting entity is the National Center for the Supply of Strategic Health Resources (CENARES), operating under the Ministry of Health (MINSA) in Peru. The procurement process is classified as Direct Procurement (Contratación Directa) and is identified by the reference number DIRECTA-DIRECTA-2-2026-CENARES/MINSA-1. The tender is specifically managed by CENARES, located in the Lima department. Atezolizumab is a targeted therapy drug, often used in oncology for the treatment of certain types of cancer, such as non-small cell lung cancer. The direct contracting method suggests that specific circumstances or regulations allow for a non-competitive bidding process. Interested suppliers specializing in pharmaceutical products, particularly oncology medications, should review the tender details provided by CENARES to understand the specific requirements, technical specifications for the Atezolizumab product, delivery schedules, and any other contractual obligations. This acquisition is crucial for maintaining the availability of essential treatments within the Peruvian public health system.

This is a supplies contract in the governance and public administration sector. Located in Peru, Latin America, this opportunity is open to firms and consortiums, with an estimated budget of PEN 4.1 million.

Published through Peru SEACE, a national government procurement portal. Public procurement tenders follow the country's national bidding regulations and may have specific eligibility and documentation requirements for the supply of goods in the governance and public administration sector. Supply contracts typically require bidders to demonstrate product compliance with technical specifications, delivery capacity, and relevant certifications. This contract has already been awarded. The information is published for transparency and market intelligence purposes.